Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,488,876
  • Shares Outstanding, K 622,036
  • Annual Sales, $ 4,386 M
  • Annual Income, $ 823,400 K
  • 60-Month Beta 1.04
  • Price/Sales 11.94
  • Price/Cash Flow 40.94
  • Price/Book 11.47
Trade EW with:

Options Overview

Details
  • Implied Volatility 23.10%
  • Historical Volatility 18.44%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 54.23% on 10/07/20
  • IV Low 23.10% on 04/09/21
  • Put/Call Vol Ratio 0.45
  • Today's Volume 1,595
  • Volume Avg (30-Day) 1,367
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 15,875
  • Open Int (30-Day) 12,260

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.47
  • Number of Estimates 12
  • High Estimate 0.50
  • Low Estimate 0.45
  • Prior Year 0.50
  • Growth Rate Est. (year over year) -6.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.44 +9.62%
on 03/19/21
86.55 -0.65%
on 04/06/21
+3.97 (+4.84%)
since 03/09/21
3-Month
78.44 +9.62%
on 03/19/21
90.33 -4.80%
on 01/11/21
-4.68 (-5.16%)
since 01/08/21
52-Week
66.23 +29.84%
on 06/15/20
92.08 -6.61%
on 12/29/20
+14.18 (+19.74%)
since 04/09/20

Most Recent Stories

More News
Prosthetic Heart Valve/ Artificial Heart Valve Market Research Report by Security Type, by Service Type, by Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19

The is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.

CRY : 22.61 (+0.09%)
EW : 85.99 (+2.17%)
LIVN : 80.00 (unch)
MDT : 122.00 (+1.12%)
NVCN.TO : 1.30 (-1.52%)
Prosthetic Heart Valve Market Research Report by Trends, by Type, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 120.90 (+0.94%)
BSX : 39.32 (+1.55%)
CRY : 22.61 (+0.09%)
EW : 85.99 (+2.17%)
NVCN.TO : 1.30 (-1.52%)
STJ : 80.82 (+0.16%)
Worldwide Structural Heart Device Competitive Analysis and Leadership Study 2021: Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, LivaNova PLC, Abott, C.R Bard, and Cryolife - ResearchAndMarkets.com

The "Worldwide Structural Heart Device Competitive Analysis and Leadership Study" report has been added to ResearchAndMarkets.com's offering.

BSX : 39.32 (+1.55%)
EW : 85.99 (+2.17%)
LIVN : 80.00 (unch)
MDT : 122.00 (+1.12%)
STJ : 80.82 (+0.16%)
Top Analyst Reports for Facebook, Adobe & Novo Nordisk

Top Analyst Reports for Facebook, Adobe & Novo Nordisk

TDOC : 181.26 (-0.58%)
PTR : 35.24 (-0.34%)
NVO : 70.12 (+1.26%)
FB : 312.46 (-0.18%)
EW : 85.99 (+2.17%)
ADBE : 504.04 (+0.84%)
Downtrend Call Working As Edwards Life Stock Falls 7.6% (EW)

SmarTrend identified a Downtrend for Edwards Life (NYSE:EW) on January 27th, 2021 at $85.11. In approximately 2 months, Edwards Life has returned 7.55% as of today's recent price of $78.68.

EW : 85.99 (+2.17%)
Interventional Cardiology Devices Market Size to Reach USD 26.84 Billion in 2028 | Rising Prevalence of Cardiovascular Diseases is Key Factors Driving Industry Growth, says Emergen Research

The global interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady revenue growth...

ABT : 120.90 (+0.94%)
BSNRF : 0.5900 (+2.25%)
BSX : 39.32 (+1.55%)
EW : 85.99 (+2.17%)
MDT : 122.00 (+1.12%)
TRUMF : 37.1100 (+2.29%)
Prosthetic Heart Valve Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 120.90 (+0.94%)
BSX : 39.32 (+1.55%)
CRY : 22.61 (+0.09%)
EW : 85.99 (+2.17%)
LIFE : 4.50 (+4.17%)
NVCN.TO : 1.30 (-1.52%)
STJ : 80.82 (+0.16%)
Prosthetic Heart Valve/ Artificial Heart Valve Market Share, Size, Trends, Industry Analysis to 2027 by Disease Type; By Technology; By Specialty; By End-Use; By Regions

The Prosthetic Heart Valve/ Artificial Heart Valve Market is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.

CRY : 22.61 (+0.09%)
EW : 85.99 (+2.17%)
LIVN : 80.00 (unch)
MDT : 122.00 (+1.12%)
NVCN.TO : 1.30 (-1.52%)
Bull of the Day: Penumbra (PEN)

Bull of the Day: Penumbra (PEN)

PEN : 272.03 (-0.01%)
EW : 85.99 (+2.17%)
Transcatheter devices market is expected to grow at a CAGR of around 12% during the forecast period 2019 to 2026

pune, India, Fri, 26 Feb 2021 01:35:23 / Comserve Inc. / -- Acumen Research and Consulting, Recently Published Report on titled "Transcatheter Devices Market Size, Share, Growth Opportunities and Forecast,...

BSX : 39.32 (+1.55%)
CRY : 22.61 (+0.09%)
EW : 85.99 (+2.17%)
NVCN.TO : 1.30 (-1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

3rd Resistance Point 88.93
2nd Resistance Point 87.46
1st Resistance Point 86.73
Last Price 85.99
1st Support Level 84.53
2nd Support Level 83.06
3rd Support Level 82.33

See More

52-Week High 92.08
Last Price 85.99
Fibonacci 61.8% 82.21
Fibonacci 50% 79.15
Fibonacci 38.2% 76.10
52-Week Low 66.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar